Page last updated: 2024-10-19

niacinamide and Leukemia, Myelomonocytic, Chronic

niacinamide has been researched along with Leukemia, Myelomonocytic, Chronic in 3 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Leukemia, Myelomonocytic, Chronic: A myelodysplastic-myeloproliferative disease characterized by monocytosis, increased monocytes in the bone marrow, variable degrees of dysplasia, but an absence of immature granulocytes in the blood.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gu, J1
Wang, Z1
Xiao, M1
Mao, X1
Zhu, L1
Wang, Y1
Huang, W1
von Bubnoff, N1
Rummelt, C1
Menzel, H1
Sigl, M1
Peschel, C1
Duyster, J1
Kosmider, O1
Chapuis, N1
Kaltenbach, S1
Coriat, R1
Boudou Rouquette, P1
Willems, L1
Chesnais, V1
Radford-Weiss, I1
Bardet, V1
Mayeux, P1
Tamburini, J1
Fontenay, M1
Bouscary, D1

Other Studies

3 other studies available for niacinamide and Leukemia, Myelomonocytic, Chronic

ArticleYear
Chronic myelomonocytic leukemia with double-mutations in DNMT3A and FLT3-ITD treated with decitabine and sorafenib.
    Cancer biology & therapy, 2017, Nov-02, Volume: 18, Issue:11

    Topics: Azacitidine; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; fms-Like Ty

2017
Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib.
    Leukemia, 2010, Volume: 24, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Female; fms-Like Tyrosine K

2010
Sustained leukemia-free state and molecular response to sorafenib in a patient with chronic myelomonocytic leukemia in transformation driven by homozygous FLT3-ITD malignant hematopoiesis.
    Clinical lymphoma, myeloma & leukemia, 2013, Volume: 13, Issue:3

    Topics: Antineoplastic Agents; fms-Like Tyrosine Kinase 3; Hematopoiesis; Humans; Leukemia, Myelomonocytic,

2013